These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 16092283)

  • 1. Recent advances in biological pumps as a building block for bioartificial hearts.
    Brimmer S; Ji P; Birla AK; Keswani SG; Caldarone CA; Birla RK
    Front Bioeng Biotechnol; 2023; 11():1061622. PubMed ID: 36741765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D bioprinting and its potential impact on cardiac failure treatment: An industry perspective.
    Birla RK; Williams SK
    APL Bioeng; 2020 Mar; 4(1):010903. PubMed ID: 32095736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dry weight determinations of normal and pathological myocardium].
    SANDRITTER W; GROSSER KD; SCHIEMER HG
    Verh Dtsch Ges Pathol; 1960; 44():192-4. PubMed ID: 13746209
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiomegaly and the transverse heart diameter.
    Williams AJ
    Chest; 1981 Apr; 79(4):489-90. PubMed ID: 6452992
    [No Abstract]   [Full Text] [Related]  

  • 5. The heart, Part One: Anatomy and physiology.
    Vickers J
    Nurs Times; 1999 Jul 28-Aug 3; 95(30):42-5. PubMed ID: 10568994
    [No Abstract]   [Full Text] [Related]  

  • 6. The heart, Part Three: Anatomy and physiology.
    Vickers J
    Nurs Times; 1999 Sep 29-Oct 5; 95(39):46-9. PubMed ID: 10745819
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative histological measurements on normal and hypertrophic hearts].
    WENDT L; HESSE H
    Virchows Arch Pathol Anat Physiol Klin Med; 1947; 314(2):294-314. PubMed ID: 20258314
    [No Abstract]   [Full Text] [Related]  

  • 8. The heart: Part one--the anatomy.
    Docherty B
    Nurs Times; 2005 Jul 26-Aug 1; 101(30):28-9. PubMed ID: 16092283
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.
    McMullen JR; Jennings GL
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):255-62. PubMed ID: 17324134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation.
    Olson EN; Backs J; McKinsey TA
    Novartis Found Symp; 2006; 274():3-12; discussion 13-9, 152-5, 272-6. PubMed ID: 17019803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resident cardiac mast cells: are they the major culprit in the pathogenesis of cardiac hypertrophy?
    Balakumar P; Singh AP; Ganti SS; Krishan P; Ramasamy S; Singh M
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):5-9. PubMed ID: 17973902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early origins of cardiac hypertrophy: does cardiomyocyte attrition programme for pathological 'catch-up' growth of the heart?
    Porrello ER; Widdop RE; Delbridge LM
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1358-64. PubMed ID: 18759854
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.